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Cytotoxic CD8+ T cells (CTLs) play amajor role in host
defense against intracellular pathogens, but a com-
plete clearance of pathogens and return to homeo-
stasis requires the regulated interplay of the innate
and acquired immune systems. Here, we show that
interferon g (IFNg) secreted by effector CTLs stimu-
lates hematopoiesis at the level of early multipotent
hematopoietic progenitor cells and induces myeloid
differentiation. IFNg did not primarily affect hemato-
poietic stem or progenitor cells directly. Instead, it
promoted the release of hematopoietic cytokines,
including interleukin 6 from bone marrow mesen-
chymal stromal cells (MSCs) in the hematopoietic
stem cell niche, which in turn reduced the expression
of the transcription factors Runx-1 and Cebpa in
early hematopoietic progenitor cells and increased
myeloid differentiation. Therefore, our study indi-
cates that, during an acute viral infection, CTLs indi-
rectly modulate early multipotent hematopoietic
progenitors via MSCs in order to trigger the tempo-
rary activation of emergency myelopoiesis and pro-
mote clearance of the infection.
INTRODUCTION
Cytotoxic CD8+ T effector cells (CTLs) are crucial for protection
against primary infection with non- or poorly cytopathic viruses
and other intracellular pathogens. Upon activation by antigen-
presenting cells, naive CD8+ T cells undergo clonal expansion,
migrate to sites of infection, and kill infected target cells via the
secretion of perforin and granzymes or Fas ligand-Fas interac-
tions. In addition, cytokines secreted by activated CTLs regu-
late the immune response and have direct antiviral effector
functions (Farrar and Schreiber, 1993; Harty et al., 2000).
For example, interferon g (IFNg) is involved in the clearance
of viral infections such as lymphocytic choriomenigitis virus
(LCMV) and mouse hepatitis virus (Parra et al., 1999; Tishon
et al., 1995).460 Cell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc.However, the resolution of infection and return to homeostasis
requires a concerted interplay between adaptive and innate im-
munity. Myeloid cells such as neutrophils and monocytes have
been shown to limit early viral spread during primary infection
(Tate et al., 2008; Thomsen and Volkert, 1983; Thomsen et al.,
1983). In addition, a central role of myeloid cells in the induction
of immunopathology in viral infections has been documented
(Dolganiuc et al., 2007; Kim et al., 2009; Yadav and Collman,
2009). Therefore, myeloid cells are involved during different
steps of a viral infection and must be continually recruited to
the site of infection (Crane et al., 2009).
In contrast to T cells that have high proliferative potential,
innate immune cells have to be replenished from bone
marrow (BM) hematopoietic stem cells (HSCs) and progenitor
cells. Inflammation-induced hematopoiesis, also known as
emergency hematopoiesis, is critical for the control of systemic
bacterial infections and may also be important in viral infections
(Takizawa et al., 2012). However, the regulation of emergency
myelopoiesis during an acute infection, including lineage-fate
decisions by HSCs and progenitor cells, remains incompletely
understood. HSCs may sense pathogens directly via pattern-
recognition receptors, such as Toll-like receptors (TLRs) (Nagai
et al., 2006). In addition, HSCs express a variety of cytokine
receptors and are able to adapt their cell-cycle status and line-
age commitment in response to cytokines produced by mature
immune cells (Takizawa et al., 2012).
Besides the direct regulation of HSCs and hematopoietic pro-
genitor cells by systemic factors, local signals from the BM HSC
niche, which consists of specialized cell subsets, such as oste-
oblasts (OBs), stromal cells, endothelial cells (ECs), and mesen-
chymal stromal cells (MSCs), are known to play a fundamental
role in the modulation of HSC function (Kiel and Morrison,
2008). Recently, MSCs have been shown to exhibit pathogen-
sensing capabilities and control monocyte emigration from BM
in response to circulating TLR ligands (Shi et al., 2011). In addi-
tion, interleukin 6 (IL-6) produced by MSCs has been shown to
regulate the fate of myeloerythroid progenitors during acute
protozoan infection (Chou et al., 2012).
In this study, we analyzed the regulation of hematopoiesis by
specific CTLs during an acute viral infection. IFNg secreted
fromCTLs enhanced the production of IL-6 in BMMSCs, thereby
increasing the numbers of early multipotent progenitor cells and
committed myeloid precursors in the BM and promoting the
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were accompanied by a transient downregulation of Runx-1
and Cebpa in hematopoietic progenitors. Our results reveal
that CTLs crucially stimulate myelopoiesis on the level of early
multipotent progenitor cells during an acute infection and define
MSCs as central regulators of IFNg-induced emergency
myelopoiesis.
RESULTS
CTLs Induce Proliferation andMyeloid Differentiation of
Early Hematopoietic Progenitor Cells
In order to mimic the CTL response during an acute viral infec-
tion, we generated effector CTLs (p14) specific for the immuno-
dominant gp33 epitope of LCMV. Then, purified p14 effector
CTLs were adoptively transferred to mice that ubiquitously ex-
press gp33 as a neo-self-antigen (H8 mice). Cells of the BM
lineage negative (lin) fraction substantially upregulated stem
cell antigen 1 (Sca-1) 2 days after adoptive transfer (Figure 1A).
Several cytokines, including interferons and IL-6, have been
shown to increase Sca-1 expression on a variety of cell types
(Chen et al., 2003; Demoulin et al., 1999; Holmes and Stanford,
2007; Snapper et al., 1991). As a consequence, the HSC-con-
taining linSca-1+c-kithi (LSK) cell fraction could not be distin-
guished from linSca-1c-kithi cells. Therefore, we focused
subsequent analyses on total linc-kithi cells containing HSCs
and progenitor cells. BM cellularity of CTL-treated H8 mice
was reduced (Figure 1B). In contrast, absolute numbers of total
lin and linc-kithi cells were increased (Figures 1C–1D). In
accordance, linc-kithi cells showed increased cell cycling,
as indicated by DAPI analysis (Figure 1E). This resulted in an
increased BM myeloid colony-forming unit (CFU) formation
per mouse in methylcellulose cultures containing stem cell fac-
tor (SCF), IL-3, IL-6, and fms-related tyrosine kinase 3 ligand
(Figure 1F). The increase in colony formation was primarily
due to a gain in monocyte CFUs (Figures S1A and S1B avail-
able online). Methylcellulose cultures in the presence of eryth-
ropoietin (EPO), G-CSF, GM-CSF, M-CSF, or IL-3 as single
cytokines revealed that the CTL-mediated increase in CFUs
was independent of the cytokine added. However, the differen-
tiation of the colonies crucially depended on the individual cyto-
kine present in the methylcellulose (Figure S1C). This suggests
that CTLs affect the proliferation of early multipotent stem or
progenitor cells.
In order to explore which stem or progenitor cell populations
are regulated by effector CTLs, we analyzed the HSC hierarchy
in linc-kithi cells after p14 CTL injection according to Wilson
et al. (2007) (Figure S1D). Numbers of dormant or activated
HSCs remained unchanged. In contrast, numbers of early multi-
potent progenitors (MPPs), as well as downstream common
myeloid progenitors (CMPs), granulocyte-monocyte progenitors
(GMPs), and megakaryocyte-erythrocyte progenitors, were sub-
stantially increased after CTL transfer (Figures 1G and S1E). As a
result, peripheral blood myeloid cell numbers increased and
peaked 4 days after p14 CTL injection. This increase was mainly
due to an accumulation of Ly6C+Ly6GSSClo inflammatory
monocytes (Figure 1G) (Rose et al., 2012). In contrast, the trans-
fer of p14 CTLs did not influence the number of common
lymphoid progenitors (CLPs). No changes in BM compositionwere found in BL/6 control mice injectedwith p14CTLs, confirm-
ing antigen specificity (Figures S1F–S1H). AlthoughHSCprolifer-
ation may be associated with increased mobilization (Baldridge
et al., 2010), CFUs in blood and spleen remained constant after
transfer of p14 CTLs to H8 mice (Figures 1H and 1I).
Sca-1 was upregulated on lin BM cells after the transfer of
p14 CTLs (Figure 1A), and, although the function of Sca-1 in
HSC biology is not entirely clear, Sca-1 seems to be involved
in HSChoming and self-renewal (Bradfute et al., 2005). However,
Sca-1-deficient H8 mice (H8xSca-1/) showed a similar in-
crease in lin cells and myeloid CFUs in the BM to that of H8
mice (Figures S1I–S1K).
CTLs Transiently Increase Myeloid Cell Production from
HSCs and Progenitor Cells
Hematopoiesis in p14 CTL-treated H8 mice displayed an
enhanced development toward the myeloid lineage (Figure 1G).
Therefore, we next analyzed whether hematopoietic stem and
progenitor cells retain this phenotype after transplantation into
recipient mice. We transferred BM cells from H8 donor mice
2 days after p14 effector CTL treatment along with congenic
rescue BM cells (at a ratio of 1:2) into lethally irradiated congenic
recipients (Figure 2A). Interestingly, BM from H8 donor mice
treated with p14 CTLs led to higher absolute numbers of donor
myeloid cells in peripheral blood of recipients in comparison to
BM from untreatedH8 donormice. In contrast, numbers of donor
lymphocytes did not differ (Figure 2B). Hematopoietic progenitor
cells in recipient mice were analyzed 12 weeks after BM transfer.
P14 CTL treatment of H8 BM donor mice resulted in higher
numbers of donor lin, linc-kithi, and LSK cells as well as
CMPs and GMPs in the recipients, whereas donor CLPs
remained unchanged (Figure 2C).
When the BMwas analyzed 35 days after initial transfer of p14
CTLs to H8 mice, homeostasis was restored (Figures S2A–S2C).
As a consequence, BM from H8 mice 35 days after p14 effector
CTL transfer reconstituted, similar to BM from naive control mice
in irradiated recipient mice. This led to a normal distribution of
myeloid and lymphoid cells in peripheral blood as well as similar
HSC and progenitor cell numbers in the BM12weeks after trans-
plantation (Figures 2D and 2E).
Therefore, the transfer of CTLs induced a transient increase of
MPPs and lineage-primed myeloid progenitors. The transfer of
these cells to irradiated recipient mice led to a long-term in-
crease in myeloid cell production, indicating that the effect is
mediated by early stem or progenitor cells able to provide
long-term reconstitution. These findings are in line with a recent
report that demonstrated intermediate-term self-renewal capac-
ity and long-termmultilineage engraftment of early MPPs (Oguro
et al., 2013).
To test whether gp33 antigen expression on hematopoietic
cells is necessary for the observed phenomena, we generated
chimeric mice expressing the H8 epitope only on radio-resistant
niche cells (Ly5.1/H8 chimeras). Transfer of p14 CTLs to these
chimeras resulted in a similar increase of myeloid progenitor
cells and CFUs, as observed after the transfer of p14 CTLs to
H8 recipients (Figure S2D; data not shown). These data suggest
that CTLs do not have to directly interact with HSCs in vivo and
that the increase in myeloid differentiation may be mediated by
soluble factors and/or additional cell types.Cell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc. 461
Figure 1. Adoptive Transfer of Effector CTLs Increases Myeloid Differentiation of Early Hematopoietic Progenitor Cells
Naive H8 mice were injected i.v. with 5 3 106 MACS-purified p14 CTLs (n = 5) or left untreated (n = 3), and BM analysis was performed 2 days later.
(A) FACS analysis of Sca-1 and c-kit expression in the BM lin fraction.
(B–D) Absolute numbers of BM cells, lin cells, and linc-kithi cells.
(E) DAPI staining of FACS-sorted linc-kithi cells. Cells of 3–8 animals per group were purified by FACS and pooled in each experiment. Pooled data from two
independent experiments are shown.
(F) Myeloid CFUs in BM.
(G) Absolute numbers of dormant and activated HSCs, MPPs, and myeloid and lymphoid progenitors in the BM (panel BM). Complete blood counts in H8 mice
before and 2, 4, and 8 days after p14 CTL injection (n = 5 each). Absolute numbers of monocyte subpopulations in peripheral blood at day 4 after p14 CTL injection
were analyzed according to Rose et al. (2012); Ly6C, CD11b+Ly6CLy6GSSClo; Ly6C+, CD11b+Ly6C+Ly6GSSClo; (n = 3 each; panel blood).
(H–I) Myeloid CFUs in spleens and blood.
Data are displayed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test).
See also Figure S1.
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Figure 2. CTLs Transiently Enhance
Myeloid Cell Production from Hematopoiet-
ic Stem and Progenitor Cells
(A) Model of transplantation. H8 donor mice were
either treated with p14 CTLs or left untreated.
(A–E) After 2 days (B and C; 2d) or 35 days (D and
E; 35d), BM cells were isolated and transplanted
into lethally irradiated congenic recipient mice
along with rescue BM cells.
(B and D) Analysis of peripheral blood donor
myeloid cells and lymphocytes in recipients (n = 4
mice each) 2, 4, 6, 8, and 12 weeks after trans-
plantation.
(C and E) After 12 weeks, numbers of BM donor
myeloid and lymphoid progenitors were deter-
mined.
Data were normalized to controls (dotted line) in
each experiment. One representative experiment
of two is shown (A–C). Data are displayed as
mean ± SEM. *p < 0.05 (Student’s t test), **p < 0.01
(two-way ANOVA).
See also Figure S2.
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Given that IFNg is amajor effectorCTL cytokinewith documented
effects on the hematopoietic system (Baldridge et al., 2010;
Binder et al., 1997, 1998; Brugger et al., 1993; Caux et al., 1992;
Chen et al., 2004; Murphy et al., 1986; Shimozato et al., 2002;
Young et al., 1997; Zhao et al., 2010), we tested its role in CTL-
mediated activation of myelopoiesis. Injecting IFNg-deficient
p14 CTLs (p14xIFNg/) intoH8mice failed to induce an increase
lin cells, linc-kithi cells, or myeloid CFUs (Figures 3A–3C), indi-
cating that IFNg secreted by activated CTLs is required for the
myeloid differentiation. To confirm the role of IFNg, we also in-
jectedp14CTLs into IFNg-receptor-deficientH8mice (H8xgR/)
and found that progenitors and myeloid CFUs did not increase
(Figures S3A–S3C). Furthermore, to mimic IFNg secretion by
CTLs, we repetitively injected recombinant murine (rm)-IFNg
intraperitoneally (i.p.) into BL/6 mice. Control mice were treated
with vehicle.Weobservedadecrease inBMcellularity 2daysafter
the injection of rm-IFNg, whereas lin cells, linc-kithi cells, and
myeloid CFUs were considerably increased (Figures 3D–3G).
Analysis of the HSC hierarchy after rm-IFNg treatment of BL/6
mice revealed similar results as injection of p14 CTLs into H8
mice (Figure S3D). A titration of the rm-IFNg dose injected re-
vealed that 105106 U are necessary to induce myeloid differen-
tiation (Figures S3E–S3K). These experiments confirm that IFNg
secreted by activated CTLs induces myeloid differentiation.
IFNg Indirectly Enhances Myelopoiesis via the BM HSC
Niche
To investigate whether IFNg acts directly on early multipotent
progenitor cells and myeloid precursors or indirectly via non-
hematopoietic cells, we generated four types of chimeric mice:
BL/6/BL/6 chimeras, where the IFNg receptor (gR) is ex-
pressed on HSCs as well as on the radio-resistant cells in the
BM (BM HSC niche); gR//BL/6 chimeras, where only niche
cells express the gR; BL/6/gR/ chimeras, where only he-matopoietic cells express the gR; and gR//gR/ chimeras
completely lacking the gR. Mice were injected i.p. with rm-
IFNg or vehicle, and BM was analyzed after 2 days. IFNg treat-
ment increased lin cells, linc-kithi cells, and myeloid CFUs in
only BL/6/BL/6 and gR//BL/6 chimeras expressing the
gR on cells of the HSC niche but not in BL/6/gR/ or
gR//gR/ chimeras (Figures 4A–4C). These findings sup-
port that IFNg does not act directly on HSCs and hematopoietic
progenitors in vivo but indirectly regulates myeloid cell produc-
tion via nonhematopoietic radio-resistant cells, most likely cells
of the BM HSC niche. However, from this experimental setup,
a contribution of other radio-resistant cells in the BM could not
be completely excluded. To analyze the role of gR-signaling on
BM stromal cells and its function in hematopoiesis in vivo more
directly, we generated tissue-engineered ossicles using a het-
erotopic bone-formation model (Song et al., 2010). In vitro ge-
nerated BM stromal cells from Ly5.1+ mice were loaded on
absorbable gelatin sponges and transplanted subcutaneously
on the right side of the back of GFP-expressing H8 mice
(H8xGFP), whereas sponges loaded with BM stromal cells
from gR/mice (Ly5.2+) were transplanted on the left side (Fig-
ure 4D). This model allows us to study the effect of CTL injections
on hematopoiesis in a setting of different stromal elements in the
samemouse. Importantly, hematopoietic and ECs originate from
the recipient mouse (H8xGFP), whereas stromal elements of the
ossicle are from the donor (Song et al., 2010). Ossicle-bearing
H8xGFP mice were injected with p14 CTLs or left untreated
4 weeks later, and BM from ossicles and bones was analyzed
48 hr later. As shown before (Figure 1F), myeloid CFUs in BM
from bones increased after p14 CTL injection. Interestingly, we
observed the same effect in BM from Ly5.1 ossicles but not
from gR/ ossicles (Figure 4E). To analyze whether HSCs
from bones and ossicles acquired a phenotype of enhanced
myeloid cell production, we transplanted BM cells from bones
and ossicles into irradiated recipients along with rescue BMCell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc. 463
Figure 3. IFNg Secreted by Effector CTLs
Increases Myeloid Differentiation
(A–C) Naive H8mice were injected i.v. with 33 106
FACS-purified p14 CTLs (n = 13) or IFNg-deficient
p14 CTLs (n = 6) or were left untreated (n = 11).
Absolute numbers of lin cells, linc-kithi cells, and
myeloid CFUs were determined after 2 days.
Pooled data from four experiments are shown.
(D–G) Naive BL/6 mice were injected i.p. with rm-
IFNg or vehicle (n = 10 each) twice daily on 2
consecutive days. Mice were sacrificed 1 day
later, and absolute numbers of BM cells, lin cells,
linc-kithi cells, and myeloid CFUs were deter-
mined. Pooled data from four experiments are
shown.
Data are displayed asmean ± SEM. *p < 0.05, **p <
0.01, ***p < 0.001 (A–C, one-way ANOVA; D–G,
Student’s t test).
See also Figure S3.
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p14 CTL-treated mice generated more myeloid cells in periph-
eral blood than BM cells from untreated mice. In contrast, BM
cells from gR-deficient ossicles generated equal numbers of pe-
ripheral bloodmyeloid cells irrespective of p14 CTL treatment. In
line with our data shown in Figure 2B, we observed no effect on
lymphoid cell production in recipient mice (Figure 4F). These
data indicate that IFNg enhances myelopoiesis via stromal cells
and not via cells of hematopoietic or endothelial origin in the BM.
Next, we analyzed gR expression on different cell subsets
of the BM HSC niche. Therefore, we isolated primary ECs
(CD45CD31+Sca-1+), OBs (CD45CD31CD51+Sca-1), and
MSCs (CD45CD31CD51+Sca-1+) from naive BL/6 mice ac-
cording to Schepers et al. (2012) (Figure S4A) and generated
BM stromal cells in vitro according to Song et al. (2010). The
functional gR consists of two subunits, the ligand binding a chain
(gRa) and b chain (gRb), which is important for intracellular
signaling (Bach et al., 1997). Only primary MSCs and in-vitro-
generated BM stromal cells expressed detectable levels of
gRa. In addition, gRb was only expressed on BM stromal cells
in vitro (Figure S4B).
To analyze the indirect effect of IFNg on myelopoiesis via BM
stromal cells in amoredefined setting in vitro,we isolatedprimary
CD45CD31 BM cells from BL/6 or gR/ mice. These cells
were cocultured alongwith linhematopoietic cells fromgR-defi-
cient mice in the presence or absence of IFNg for 2 days. In this
setting, IFNg can only act on hematopoietic cells indirectly via
CD45CD31BMcells. IFNg enhanced themyeloid CFU capac-
ity of gR/ lin cells in the presence of BL/6 CD45CD31 BM
cells but not gR/ CD45CD31 BM cells (Figure 4G).
In summary, these results indicate that IFNg indirectly in-
creases the myeloid CFU capacity of hematopoietic progenitors
via CD45CD31 BM stromal cells.
IFNg-Induced Expansion of Early Myeloid Progenitors Is
Mediated via IL-6 Secreted by MSCs
To explore the mechanism by which IFNg increases myelopoie-
sis via BM stromal cells in more detail, we performed a TaqMan
low-density array of hematopoiesis-regulating genes expressed464 Cell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc.by the BM stromal cell lines St-2 and S-17 upon treatment with
IFNg in vitro (Table S1). IFNg regulated the expression of
different genes in these cell lines, including the expression of he-
matopoietic cytokines. Interestingly, IL-6was the only factor that
was strongly upregulated in both cell lines (Figure S4C). There-
fore, we analyzed IFNg-dependent IL-6 upregulation and further
tested for the expression of the hematopoiesis-regulating cyto-
kines IL-3 and thrombopoietin (TPO) by real-time RT-PCR. As
positive controls, we analyzed the expression of the IFNg-
responsive gene Irgm1 (Baldridge et al., 2010) as well as gRa
and gRb, which have been reported to be regulated by IFNg
(Bach et al., 1997). Importantly, we confirmed that IFNg upregu-
lated IL-6mRNA in St-2 and S-17 BM stromal cell lines. In addi-
tion, we observed an increase of TPO mRNA in both cell lines,
whereas IL-3 mRNA was undetectable (Figure S4D).
To verify that IFNg does not primarily affect the expansion
of colony-forming hematopoietic progenitors directly but stimu-
lates BM stromal cells to secrete IL-6, we performed coculture
experiments with the St-2 BM stromal cell line or magnetic-acti-
vated cell sorting (MACS)-purified CD45CD31 BM stromal
cells for subsequent in vitro experiments. In the first experiment,
we blocked IL-6 in cocultures of the St-2 BM stromal cell line and
gR-deficient c-kithi cells. Blocking IL-6 completely abolished the
IFNg-mediated increase in myeloid CFUs (Figure 5A). Subse-
quently, we cocultured gR-deficient c-kithi cells with IL-6-
competent or -deficient CD45CD31 BM cells in the presence
of rm-IFNg. IFNg increasedmyeloid CFUs only in the presence of
IL-6-competent CD45CD31 BM cells (Figure 5B).
To analyze the source of IL-6 in the BM in response to IFNg
in vivo, we isolated different BM cell subsets from IFNg- or
vehicle-treated mice. IL-6 mRNA was predominantly upregu-
lated in nonhematopoietic CD45 cells (Figure S5A). To define
the IL-6-secreting cell population within the CD45 BM cell frac-
tion in more detail, we fluorescence-activated cell sorting
(FACS)-purified ECs, OBs and MSCs (Schepers et al., 2012)
from naive BL/6 and gR/ mice. These cells were cultured in
the presence of rm-IFNg or vehicle in vitro andmRNA and super-
natants were analyzed after 48 hr. Only OBs and MSCs from
BL/6 mice responded to IFNg as indicated by elevated Irgm1
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mRNA expression specifically in BL/6 MSCs, resulting in detect-
able IL-6 protein secretion (Figures 5D and 5E).
As shown before (Reynaud et al., 2011), the IL-6 receptor
alpha chain is only expressed at the stage of MPPs and down-
stream myeloid precursors, whereas it is lacking on bona fide
HSCs and on CLPs (Figure S5B). In vitro incubation with recom-
binant IL-6 increased the CFU capacity of FACS-purified MPPs
but not CMPs or GMPs, indicating that MPPs are the cells that
predominantly respond to IL-6 (Figure 5F). To confirm our results
in vivo, we treated IL-6-deficient and BL/6 mice with rm-IFNg or
vehicle i.p. IFNg induced myeloid differentiation in BL/6 mice but
not IL-6/mice (Figures 5G–5I). In line with our previous results
(Figures 1G and S3D–S3K), analysis of the HSC hierarchy in
these mice revealed that IFNg-induced IL-6 affected only early
MPPs and myeloid precursors and not HSCs or lymphoid pro-
genitors (Figures S5C–S5K).
Next, we FACS purified linc-kithi cells from rm-IFNg- or
vehicle-treated BL/6 and IL-6-deficient mice and analyzed the
expression of genes known to regulate myeloid differentiation.
Runx-1 and Cebpa mRNA expression was downregulated by
IFNg treatment in BL/6 mice but remained unchanged in IL-
6/ mice (Figures 5J and 5K). Other genes involved in myeloid
differentiation, such as Pu.1, c-myc, Cebpb, Id1, and Id2, were
not regulated by IL-6 in this assay (data not shown). In summary,
these results indicate that IFNg stimulates IL-6 secretion from
MSCs. IL-6 concomitantly reduces the expression of Runx-1
and Cebpa in hematopoietic progenitor cells, leading to an
increase in myeloid differentiation.
CTL-Secreted IFNg Induces Myelopoiesis during Acute
Viral Infection
Next, we investigated the physiological relevance of our findings
during an acute infection that is controlled by CTLs (Buchmeier
et al., 1980). The inoculation of BL/6 mice with LCMV results in
virus titers peaking 4 days after infection, leading to a maximal
CTL response 8 days after infection. Three groups of mice (naive
BL/6, CD8-depleted BL/6, and IFNg-deficient) were inoculated
intravenously (i.v.) with 200 plaque-forming units (pfu) of
LCMV-WE, and the BM compartments were analyzed 4, 8, 12,
and 16 days later. Concomitant to the development of the CTL
response 8 days after infection, we observed LCMV-gp33-spe-
cific CD8+ T cells in the BM of BL/6 mice, as analyzed by
tetramer staining and intracellular IFNg staining after restimula-
tion (data not shown). LCMV infection was accompanied by a
decrease in BM cellularity (Figure 6A). Importantly, numbers
of linc-kithi cells and myeloid CFUs were only increased in
LCMV-infected BL/6 mice at the peak of the CTL response
(Figures 6B, 6C, and S6A). This effect was neither present in
CD8-depleted BL/6 nor in IFNg/ mice. Consequently, blood
myeloid cell numbers increased 8 days postinfection in BL/6
mice but not in CD8-depleted BL/6 or in IFNg/ mice (Fig-
ure 6D). BM and blood cell numbers were similar in all three
groups of mice 16 days after infection. These experiments sug-
gest that CD8+ T cells and IFNg are necessary for augmenting
myelopoiesis during LCMV infection.
Given that LCMV-WE is an IFNg-susceptible strain (Moskophi-
dis et al., 1994) and that primary LCMV infection is almost exclu-
sively controlled by CTLs (Buchmeier et al., 1980), data obtainedfrom LCMV-infected IFNg/ or CD8-depleted BL/6 mice could
have resulted from LCMV persistence rather than from the
absence of CTL-secreted IFNg, stimulating myelopoiesis. To
analyze the effect of IFNg on niche cells versus BM cells in
mice competent of eliminating LCMV, mixed Ly5.1/gR/ (ratio
1:1) BM chimeric mice were generated in Ly5.1 and gR/ recip-
ients. BM cells from Ly5.1 and gR/ donors residing in wild-type
niches (Ly5.1 recipients) generated substantially more myeloid
CFUs 8 days after LCMV infection in comparison to BM cells
residing in niches lacking the gR (gR/ recipients) (Figure 6E).
These results indicate that, during LCMV infection, IFNg secreted
by activated CTLs augments myelopoiesis via niche cells.
Importantly, serum IFNg levels secreted by activated immune
cells during LCMV infection were quite comparable to the levels
measured after the injection of effector p14 CTLs into H8 mice
andafter the injectionof106Urm-IFNg intoBL/6mice (FigureS6B).
This indicates that CTL activity and IFNg levels in the two model
situations analyzed are comparable to a physiological infection.
IFNg-Mediated IL-6 Production by the BM HSC Niche
Promotes Myelopoiesis and Enhances Viral Clearance
during Acute LCMV Infection
To verify that the effect of IFNg is dependent on IL-6 in vivo, we
infected naive BL/6 and IL-6/ mice with 200 pfu of LCMV-WE
i.v. and analyzed the BM 8 days later. LCMV infection induced
myeloid differentiation in BL/6 mice but not IL-6/mice. Impor-
tantly, IL-6 only increased early MPPs and lineage-primed
myeloid precursors but did not affect HSCs or lymphoid progen-
itors in this experiment (Figures S7A–S7I).
To further demonstrate that the effect of IFNg is mediated via
IL-6 secreted by the BMHSC niche during acute LCMV infection,
we infected two groups of chimeric mice: a first group with IL-6-
competent niche cells (BL/6/BL/6 and IL-6//BL/6) and a
second group with IL-6-deficient niche cells (BL/6/IL-6/
and IL-6//IL-6/). BM cellularity, dormant HSCs, and acti-
vated HSCs did not differ between the four types of chimeric
mice 8 days after LCMV infection. In contrast, lin cells, linc-
kithi cells, MPPs, and myeloid precursors, but not lymphoid pre-
cursors, were increasedwhen the nichewas IL-6 competent (Fig-
ures 7A–7H; data not shown). Interestingly, Ly6C+Ly6GSSClo
monocytes that are involved in phagocytosis and pathogen clear-
ance (Shi and Pamer, 2011) were increased in absolute numbers
in spleens of mice with BL/6 niche cells in comparison to mice
with IL6/ niche cells (Figure 7I). This correlated with an
enhanced viral clearance in chimeras with an IL-6-competent
niche (Figure 7J). In summary, our data support that CTL-
secreted IFNg increases myelopoiesis via niche-cell-secreted
IL-6 and thereby contributes to virus control.
To extend our findings to other viral infections, BL/6mice were
immunized with vesicular stomatitis virus (VSV) or vaccinia virus
(VV). Similar to LCMV infection, VSV and VV infections increased
the numbers of linc-kithi cells and myeloid CFUs (Figures S7J–
S7L), suggesting that CTL-driven myelopoiesis is comparably
regulated in different viral infections.
DISCUSSION
Host protection against viruses requires a concerted interaction
between the innate and acquired immune systems. However,Cell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc. 465
Figure 4. IFNg Indirectly Enhances Myelopoiesis via the BM HSC Niche
(A–C) Four groups of chimeric mice were generated: BL/6/BL/6, gR//BL/6, BL/6/gR/, and gR//gR/. Mice were injected i.p with rm-IFNg or
vehicle on 2 consecutive days, and BM was analyzed 1 day later. Numbers of lin cells (A), linc-kithi cells (B), and myeloid CFUs (C) in chimeras after treatment
(n = 4 mice per group).
(D) Model of ossicle generation in GFP-expressing H8 mice allowing the study of the effect of CTL injections on hematopoiesis in a setting of different stromal
elements in the same mouse.
(E) CFU capacity of 5 3 104 BM cells from bones and ossicles of p14 CTL-injected versus untreated mice.
(F) 53 104 BM cells from bones or ossicles were transplanted along with 53 105 congenic rescue BM cells (ratio 1:10) into different groups of lethally irradiated
recipient mice. Analysis of peripheral blood donor myeloid cells and lymphocytes in recipients 2, 4, 6, and 8 weeks after transplantation.
(legend continued on next page)
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Figure 5. IFNg-Induced Expansion of Early
Myeloid Progenitors Is Mediated via IL-6
Secreted by MSCs
(A) 5 3 105 gR/ linc-kithi cells were cocultured
in duplicates with 5 3 104 St-2 BMSCs with or
without 1,000 U/ml rm-IFNg in the presence or
absence of 2 mg/ml blocking anti-IL-6 for 2 days.
On day 2, cells were counted, and 5 3 103 cells
were transferred into methylcellulose. CFUs of 53
103 cells were determined after 7 days, and total
CFUs per well of coculture were calculated.
(B) 53 105 gR/ linc-kithi cells were cocultured in
duplicates with 5 3 104 CD45CD31 BM cells
from BL/6 or IL-6/ mice with or without
1,000 U/ml rm-IFNg. CFUs of 5 3 103 cells were
determined as described in (A).
(C–E) 10 3 103, 60 3 103, and 5 3 103 FACS-
sorted ECs, Obs, and MSCs, respectively, were
cultured in the presence or absence of 1,000 U/ml
rm-IFNg. After 2 days of culture, cells were
analyzed for Irgm1 (C) and IL-6 (D) mRNA
expression, and IL-6 protein levels (E) were
determined. DL, detection limit; nd, CT value > 35
or not detectable.
(F) CFUs of FACS-purified MPPs, CMPs, and
GMPs in methylcellulose in the presence or
absence of 20 ng/ml rh-IL-6. Data were normal-
ized to control conditions (without rh-IL-6).
(G–I) Naive BL/6 or IL-6-deficient mice were in-
jected i.p. with rm-IFNg or vehicle twice daily on 2
consecutive days (n = 4–6 mice each). Absolute
numbers of lin cells (G), linc-kithi cells (H), and
myeloid CFUs (I) were determined 1 day later, and
Runx-1 (J) and CebpamRNA (K) expression levels
were measured in FACS-purified linc-kithi cells.
Data are displayed as mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001 (A, one-way ANOVA; B,
GK, Student’s t test; F, one-sample Student’s
t test).
See also Figure S5.
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during a viral infection remains poorly defined. In contrast to
CTLs that can undergo clonal expansion, the demand of postmi-
totic innate immune cells, such as granulocytes and monocytes,
is met by increased production from BM hematopoietic progen-
itors and by accelerated release into the circulation. Here, we
identify amechanism bywhich the adaptive immune system reg-
ulatesmyeloid cell production during virus-infection-induced he-
matopoiesis. Activated CTLs increase IL-6 production by MSCs,
which induces the proliferation and differentiation of myeloid
progenitors in the BM, resulting in an increased output ofmyeloid
cells. Several mechanisms involved in the regulation of innate
immune cell production by systemic and local inflammatory sig-
nals have already been elucidated, including TLR activation and
soluble factors such as type I and type II interferons (Takizawa
et al., 2012). IFNg has pleiotropic effects on many cell types,(G) 105 gR-deficient lin BM cells were cocultured with 104 freshly isolated BL/6 o
After 2 days, 53 103 cells were transferred into methylcellulose, and CFUs were d
duplicates and triplicates is shown.
Data are displayed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (A–C and
See also Figure S4.including HSCs and hematopoietic progenitor cells. In IFNg
transgenic mice, chronic overexpression of IFNg in the BM
decreased the numbers of myeloid progenitors (Young et al.,
1997). Furthermore, in a mouse model of lymphocyte-infusion-
induced BM failure, HSC destruction was partially mediated by
IFNg (Chen et al., 2004). Moreover, chronically LCMV-infected,
perforin-deficient mice developed lethal pancytopenia, an effect
mediated by IFNg secreted from CTLs (Binder et al., 1998). In
accordance with these findings, IFNg suppressed myeloid
colony formation from HSCs in vitro (Broxmeyer et al., 1985,
1983; Murphy et al., 1986). In contrast to this inhibitory effect
of IFNg on hematopoiesis, accumulating evidence from infection
models suggests that IFNg induces an expansion of HSCs and
myeloid progenitors and modulates the production of mature
myeloid cells (Baldridge et al., 2010; Belyaev et al., 2010; de
Bruin et al., 2012; MacNamara et al., 2011a, 2011b; Zhaor gR/ CD45CD31 BM cells in the presence or absence of 100 U rm-IFNg.
etermined 1 week later. One representative experiment out of two performed in
E, Student’s t test; F, two-way ANOVA; G, one-way ANOVA).
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Figure 6. CTL-Secreted IFNg Induces Mye-
lopoiesis during Acute Viral Infection
(A–C) BM of naive or LCMV-infected (200 pfu)
BL/6, CD8-depleted BL/6, and IFNg/ mice
was analyzed 4, 8, 12, and 16 days after infec-
tion (n = 9–13 per group). BM cells (A), linc-kithi
cells (B), and myeloid CFUs (C) per mouse are
shown.
(D) Complete blood counts before and 4, 8, 12,
and 16 days after infection (n = 5 per group).
(E) Mixed Ly5.1/gR/ (1:1) BM chimeras in Ly5.1
and gR/ recipients were infected with 200 pfu
LCMV 8 weeks after reconstitution. Ly5.1 and
gR/ lin BM cells in each mouse were sepa-
rated by FACS and plated in methylcellulose
8 days later, and myeloid CFUs were determined
after 7 days. The graph indicates the fold in-
crease of Ly5.1 and gR/ CFUs in LCMV-in-
fected versus -uninfected mice. Pooled data from
four to five independent experiments in Ly5.1
recipients (wild-type niche, n = 35 mice) versus
gR/ recipients (gR/ niche, n = 20 mice) are
shown.
Data are displayed as mean ± SEM. *p < 0.05, **,
##p < 0.01, ***p < 0.001 (A–C, one-way ANOVA;
* and ** indicate a comparison of BL/6 versus
CD8-depleted BL/6 versus IFNg/ mice at day 8
after infection, whereas ## indicates a comparison
of BL/6 at day 8 versus days 0 and 4; D, two-way
ANOVA; E, Student’s t test).
See also Figure S6.
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induced proliferation of human CD34+ stem and progenitor cells
from healthy donors and leukemia patients in vitro (Brugger et al.,
1993; Caux et al., 1992). Similarly, IFNg induces the expansion
of leukemia stem cells in vivo (Schu¨rch et al., 2013). In accor-
dance with the findings favoring a positive and activating effect
of IFNg on myelopoiesis, we now show that IFNg is the main
effector of the CTL-mediated expansion of early multipotent
progenitor cells and downstream myeloid precursors in the
BM. IFNg did not affect numbers of early HSCs in vivo but
increased MPPs and myeloid progenitor cells, resulting in an
accumulation of monocytes in the periphery. The discrepancies
between the reported positive and negative effects of IFNg on
hematopoiesis may be best explained by the duration of IFNg
stimulation (acute versus chronic) and compensatory mecha-
nisms that can only be studied in vivo, for instance, as we
show here, the IFNg-triggered secretion of hematopoietic cyto-
kines such as IL-6.
Surprisingly, IFNg did not act on MPPs and myeloid progeni-
tors directly but did so indirectly via cells of the hematopoietic
niche. The generation of BM-stromal-cell-derived ossicles
allowed us to dissect the function of different cell types within
the hematopoietic niche. Experiments using ossicles from
gR/ BM stromal cells in BL/6 recipients clearly indicated that
BM stromal cells sense IFNg and regulate myelopoiesis. BM
stromal cells have been shown to be able to present antigen
on major histocompatibility complex (MHC) class I and to
interact with CTLs (Stagg et al., 2006). Moreover, BM stromal
cells can be infected directly with LCMV in vitro (data not shown)468 Cell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc.and have a well-documented role in the regulation of hematopoi-
esis (Kiel and Morrison, 2008). We found that, in response to
IFNg, BM stromal cells secrete several important cytokines regu-
lating hematopoiesis, including IL-6 and TPO. Our in vitro and
in vivo experiments in IL6/ chimeric mice defined that IL-6
secreted by BM stromal cells is necessary for IFNg-stimulated
myelopoiesis. Separation of the BM stromal cells according to
Schepers et al. (2012) revealed that MSCs, but not OBs or
ECs, secrete IL-6 in response to IFNg. Therefore, our findings
are in line with and extend a recent report by Chou et al. (2012)
demonstrating that protozoan infection in mice induces myeloid
progenitor expansion via BM-stromal-cell-derived IL-6. How-
ever, IL-6 may act in combination with or may rely on other not
still unidentified cytokines present in the BM niche to fully elicit
its effects on myeloid cell differentiation. Earlier studies demon-
strated that IFNg alone and in combination with other cytokines
such as TNFa causes the release of a number of different cyto-
kines includingG-CSF or GM-CSF from various cell types. These
secreted cytokines affected differentiation and colony formation
of myeloid blasts and progenitor cells (Geissler et al., 1989; Lu
et al., 1988; Piacibello et al., 1986).
Myeloid lineage fate of hematopoietic progenitors is regu-
lated by several transcription factors during normal and
dysregulated hematopoiesis. Furthermore, alterations in their
expression have been reported for myeloid leukemias (Rose-
nbauer and Tenen, 2007). Recently, it was demonstrated that
the deletion of Runx-1, a key regulator of embryogenesis and
hematopoiesis, results in reduced transcription of Cebpa, a
key factor in myelopoiesis. This resulted in myeloproliferation,
Figure 7. IL-6 Production by the BM HSC Niche Promotes Myelopoiesis and Enhances Viral Clearance during Acute LCMV Infection
(A–J) Four types of chimeric mice were generated: BL/6/BL/6, IL-6//BL/6, BL/6/IL-6/, and IL-6// IL-6/. Mice were injected with 200 pfu of LCMV
12 weeks after reconstitution, and BM and spleen were analyzed 8 days after infection. Absolute numbers of total cells (A), lin cells (B), linc-kithi cells (C),
dormant HSCs (D), activated HSCs (E), MPPs in the BM (F–H), Ly6C+ monocytes (CD11b+Ly6C+Ly6GSSClo) (I), and virus titers in spleens (J) were determined
(n = 3 mice each). Data are displayed as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (one-way ANOVA).
See also Figure S7.
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now show that, in response to IFNg, IL-6 reduced the transcrip-
tion of Runx-1 and Cebpa. In line with these findings, the
absence of Cebpa was shown to enhance self-renewal and re-
population capacity of HSCs in vivo (Zhang et al., 2004).
Interestingly, transplantations of BM cells from p14 CTL-
treated H8 mice during the acute phase of the CTL response
(day 2) revealed that the increase in myeloid cell production is
stably detectable up to 12 weeks in the blood and BM of recip-
ient mice. This indicates that early progenitor cells that are
able to reconstitute in the intermediate or long term mediate
the effect in irradiated recipients. In contrast, when BM cells
were transplanted after resolution of the CTL response (day
35), reconstitution in recipient mice did not differ in comparison
to controls. These data suggest that IFNg secreted by activated
CTLs transiently enhances myeloid cell production from early
progenitor cells, which is restored to steady-state conditions
upon the resolution of the CTL response. Given that CTL or
IFNg treatment did not affect the numbers of dormant and acti-
vated HSCs and that HSCs did not express the IL-6 receptor
(Figure S5B) (Reynaud et al., 2011), MPPs may contribute to in-
termediate-term hematopoiesis in BM-transplanted hosts. This
concept is supported by recent findings demonstrating that early
MPPs exhibit intermediate-term self-renewal capacity and long-
term multilineage engraftment (Oguro et al., 2013). Furthermore,
myeloid-biased hematopoietic progenitor cells extensively self-
renew and maintain their phenotype through serial transplanta-
tions (Muller-Sieburg et al., 2004).
Our study reveals a mechanism of myelopoiesis regulation
by CTLs during an acute viral infection. Different myeloid cells
are involved in the control of viral pathogens (Belyaev et al.,
2010; Dolganiuc et al., 2007; Racine et al., 2011; Tate et al.,
2008; Thomsen and Volkert, 1983; Thomsen et al., 1983). For
example, inflammatory Ly6C+Ly6GSSClo monocytes are in-volved in phagocytosis and are responsible for successful clear-
ance of pathogens (Shi and Pamer, 2011). In a model of West
Nile virus infection, Ly6C+ monocytes were recruited to the
site of infection and enhanced viral clearance (Lim et al.,
2011). We found that, during LCMV infection, the numbers of
Ly6C+Ly6GSSClo monocytes were increased in mice possess-
ing IL-6-competent BM stroma. The increased numbers of
Ly6C+Ly6GSSClo monocytes correlated with a more efficient
virus control.
In summary, MSCs are central regulators of emergency
myelopoiesis during an acute viral infection. In response to
CTL-secreted IFNg, they produce IL-6, leading to the downre-
gulation of Runx-1 and Cebpa in myeloid progenitors and
increased myeloid differentiation. A better understanding of the
regulatory mechanisms between adaptive and innate immunity,
in particular on the level ofMSCs, may lead to therapeutic oppor-
tunities for patients suffering from infections and hematological
diseases.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J (BL/6) mice were from RCC Laboratories. Ubi-GFP mice (Schaefer
et al., 2001) were kindly provided by C. Mu¨ller (Institute of Pathology, Univer-
sity of Bern). IL-6-deficient mice (Kopf et al., 1994) were kindly provided by
M. Kopf (Swiss Federal Institute of Technology). Sca-1-deficient mice (Stan-
ford et al., 1997) were kindly provided by T. Pedrazzini (Experimental
Cardiology Unit, University of Lausanne). Ly5.1 (CD45.1+) mice, p14 TCR
transgenic mice (Pircher et al., 1989) specific for the LCMV glycoprotein
epitope 33–41 (gp33), H8 transgenic mice (Ehl et al., 1998) ubiquitously ex-
pressing LCMV-gp33 under the control of a MHC class I promoter, IFNg-defi-
cient mice (Dalton et al., 1993), and IFNg-receptor-deficient mice (Huang
et al., 1993) were obtained from the Institute for Laboratory Animals. All
mice were on a BL/6 background. Animal experiments were approved by
the local experimental animal committee and performed according to Swiss
laws for animal protection.Cell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc. 469
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LCMV strain WE was provided by R.M. Zinkernagel (University of Zu¨rich) and
propagated and titrated as previously described (Matter et al., 2006).
Generation of Effector CTLs
1 3 106 splenocytes from p14 TCR transgenic mice (p14 mice) or IFNg-defi-
cient p14 mice (all CD45.1+) were adoptively transferred to BL/6 mice. BL/6
mice were infected with 104 pfu LCMV 12–18 hr later. After 7 days, spleens
were harvested, and CD8+ T cells were purified by MACS aCD8 beads and
LS columns. For experiments using IFNg-deficient p14 CD8+ T cells, MACS-
purified cells were sorted with FACS for CD8, CD45.1, Va2 TCR, and
Vb8.1,b8.2 TCR. 3–5 3 106 purified CTLs were intravenously injected into
recipient mice.
IFNg Treatment
For IFNg treatment in vivo, mice were injected i.p. with 2.53 105 U of rm-IFNg
(ProSpec) twice daily on 2 consecutive days before the day of analysis (total of
106 U per mouse).
Generation of BM Chimeras
Mice were lethally irradiated (23 6.5 Gy with a 4 hr interval) with a Gammacell
40 (MDS Nordion). For chimeras generated from p14 effector CTL-treated
donor mice, whole BM cells or hematopoietic cells from ossicles were trans-
planted along with congenic competitor BM cells at ratios of 1:2 and 1:10,
respectively. For LCMV infection experiments, chimeras were generated
with lin donor BM cells. During 12 weeks after transplantation, antibiotics
were added to the drinking water. Chimerismwas analyzed by FACS of periph-
eral blood after 8 weeks.
Isolation of Niche Cells
OBs, ECs, andMSCswere isolated, analyzed, and purified by FACS according
to (Schepers et al., 2012). In brief, bones were crushed and digested in PBS
with collagenase and DNase for 1 hr at 37C at 110 revolutions per min. Cells
were stained for CD51, Sca-1, and CD31. Hematopoietic cells were excluded
with lineagemarkers, CD45, and Ter-119. Fresh primary BM stromal cells were
isolated by removing CD31+ cells from the CD45 fraction with MACS.
Generation of BM Stromal Cells and Heterotopic Tissue-Engineered
Ossicles
BM stromal cells and ossicles were generated as previously described (Song
et al., 2010). In brief, whole BMwas seeded to a density of 1–23 106 cells/cm2
and grown in a-MEM10% fetal calf serum (FCS), 100 U/ml penicillin, 100 mg/ml
streptomycin, and 2 mM L-glutamine at 37C. Nonadherent cells were
removed after 3 days. Medium was changed two times per week. After 10–
14 days, adherent cells were detached with trypsin and collagenase and dis-
pase. For FACS analysis, cells were depleted from CD45+ cells by MACS and
were stained for Sca-1, CD44, CD29, and Thy1. For ossicle generation, 33 106
cells were resuspended in 50 ml of Hank’s Balanced Salt Solution (Sigma-
Aldrich) and added onto wet Gelfoam absorbable gelatin sponges (Pfizer) in
1.5 ml Eppendorf tubes. Sponges were incubated for 1.5 hr at 37C and trans-
planted subcutaneously onto the backs of recipient mice. Mice were treated
daily with an anabolic dose of 40 mg/kg recombinant human (rh)-PTH 1-34
(ProSpec) for 21 days.
Myeloid Colony-Forming Assays
For BM and spleens, 3.3 3 103 lin cells were cultured in MethoCult base
medium (STEMCELL Technologies) supplemented with 15% FCS, 20% BIT
(50 mg/ml BSA in Iscove’s modified Dulbecco’s medium, 1.44 U/ml rh-insulin
[Actrapid, Novo Nordisk], and 250 ng/ml human Holo Transferrin [ProSpec]),
100 mM 2-b-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml streptomycin,
2 mM L-glutamine, and a cytokine mix of 50 ng/ml rm-SCF, 10 ng/ml rm-IL-
3, 10 ng/ml rh-IL-6, and 50 ng/ml rm-Flt3-ligand (all from ProSpec). For blood
CFUs, 500 ml of whole blood was plated in methylcellulose after red blood cell
lysis. In some cultures, the cytokines rm-IL-3 (10 ng/ml), rm-G-CSF (10 ng/ml),
rm-GM-CSF (10 ng/ml), rm-M-CSF (10 ng/ml), or rh-EPOa (1 U/ml; all from
Prospec) were used alone or in combination with rm-SCF (50 ng/ml) as indi-
cated. For CFUs from purified MPPs, CMPs, and GMPs, cells were cultured
with the cytokine mix described above with the modification that either no470 Cell Stem Cell 14, 460–472, April 3, 2014 ª2014 Elsevier Inc.IL-6 or 20 ng/ml rh-IL-6 were added to the culture. Colonies were enumerated
after 7 days (R30 cells per colony).
Statistical Analysis
Data are represented as mean ± SEM. Data were analyzed with one-way
ANOVA and Tukey’s multiple comparison test or Dunnett’s multiple compari-
son test, Student’s t test (two-tailed), one-sample Student’s t test, or two-way
ANOVA and Bonferroni post hoc test. p < 0.05 was considered significant.
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